Table 2. Phenotypic drug-susceptibility; states: BN,KB, KN, YB, JG, KT and a few samples noted NGA (unknown) or FXX (France).
| Antibiotic | Resistance | Sensitive | Intermediate | Unknown | Total |
|---|---|---|---|---|---|
| Isoniazid (INH) | 68 | 91 | 4 | 2 | 165 |
| Ethambutol (EMB) | 4 | 150 | 4 | 7 | 165 |
| Rifampicin (RIF) | 118 | 45 | 0 | 2 | 165 |
| Streptomycin (SRM) | 14 | 138 | 5 | 8 | 165 |
| pyrazinamide (PZA) | 0 | 149 | 5 | 11 | 165 |
| fluoroquinolones (FQs) | 0 | 150 | 5 | 10 | 165 |
| amikacin (AMK) | 18 | 131 | 5 | 11 | 165 |
| ethionamide (ETH) | 0 | 149 | 5 | 11 | 165 |
| para-aminosalicylic acid (PAS) | 0 | 149 | 5 | 11 | 165 |
| linezolid (LZD) | 0 | 149 | 5 | 11 | 165 |
| kanamycin (KAN) | 18 | 131 | 5 | 11 | 165 |
| capreomycin (CPR) | 18 | 131 | 5 | 11 | 165 |
| prothionamide (PTO) | 0 | 150 | 4 | 11 | 165 |